Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

NCT01295060 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Program was terminated for business reasons

Conditions

Acromegaly

Interventions

DRUG: Octreotide

Sponsor

Endo Pharmaceuticals